Sotac PharmaceuticalsNSE:SOTAC 61 Days Payable is 150.40 as of Sep. 2025, which is 19% above its 10-year median of 126.46. GuruFocus rates NSE:SOTAC with a GF Score™ of 61/100 and a GF Value™ of ₹110.01 (Fairly Valued). The stock has 6 warning signs investors should review. Among 922 Drug Manufacturers companies, Sotac Pharmaceuticals ranks better than 80.04% on this metric.
Sotac Pharmaceuticals Days Payable Historical Data
* Premium members only.
The historical data trend for Sotac Pharmaceuticals's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Sotac Pharmaceuticals's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sotac Pharmaceuticals Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sotac Pharmaceuticals's Days Payable distribution charts can be found below:
* The bar in red indicates where Sotac Pharmaceuticals's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Sotac Pharmaceuticals's Days Payable for the fiscal year that ended in Mar. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sotac Pharmaceuticals (NSE:SOTAC) has a Days Payable of 150.40 as of Sep. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Sotac Pharmaceuticals and its competitors. This is 19% above median its historical median of 126.46. Over the past decade, Sotac Pharmaceuticals' Days Payable has ranged from 111.83 to 190.99. According to the industry distribution chart, Sotac Pharmaceuticals ranks #184 out of 922 companies in the Drug Manufacturers industry, placing it in the top 20%.
Is Sotac Pharmaceuticals' Days Payable too high?
Sotac Pharmaceuticals' current Days Payable of 150.40 is 19% above median its 10-year median of 126.46. Over the past 10 years, this metric has ranged from a low of 111.83 to a high of 190.99. The Drug Manufacturers industry median Days Payable is 90.61. Sotac Pharmaceuticals' value of 150.40 is 66% above this industry median. Based on the distribution chart, Sotac Pharmaceuticals ranks #184 out of 922 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Sotac Pharmaceuticals has a GF Score™ of 61/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sotac Pharmaceuticals' Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Sotac Pharmaceuticals ranks #184 out of 922 companies for Days Payable. This places Sotac Pharmaceuticals in the top 20% of its industry — outperforming the majority of peers. The industry median Days Payable is 90.61. Sotac Pharmaceuticals' value of 150.40 is 66% above this benchmark. Historically, Sotac Pharmaceuticals' own Days Payable has ranged from 111.83 to 190.99 over the past decade. While the company's 10-year median is 126.46 vs. the industry median of 90.61, Sotac Pharmaceuticals has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.61, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sotac Pharmaceuticals's current Days Payable of 150.40 is 66% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Sotac Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sotac Pharmaceuticals's current Days Payable is 150.40, which is 19% above median its own 10-year median of 126.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sotac Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Sotac Pharmaceuticals (NSE:SOTAC) is currently considered Fairly Valued. The stock's GF Value™ is ₹110.01, compared to a current price of ₹101.00 — trading 8.2% below its estimated fair value. The current Days Payable is 150.40, which is 19% above median its 10-year median of 126.46 and 66% above the Drug Manufacturers industry median of 90.61. Sotac Pharmaceuticals' overall GF Score™ is 61/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Sotac Pharmaceuticals (NSE:SOTAC), the current Days Payable is 150.40 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sotac Pharmaceuticals (NSE:SOTAC) Overvalued in 2026?
Based on GuruFocus' analysis, Sotac Pharmaceuticals stock appears to be undervalued.
The current stock price of ₹101.00 is trading 8.2% below its estimated GF Value™ of ₹110.01.
GuruFocus considers Sotac Pharmaceuticals to be Fairly Valued.
Key valuation signals for NSE:SOTAC:
Days Payable: 150.40 (19% above median its 10-year median of 126.46)
GF Value™: ₹110.01 vs. price of ₹101.00 (8.2% below fair value)
Industry Position: 66% above the Drug Manufacturers median (#184 of 922)
No single metric tells the full story. See the NSE:SOTAC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sotac Pharmaceuticals Ltd operates chiefly in pharmaceutical manufacturing, serving a broad range of therapeutic segments including anti-diabetic, anti-psychotic, vitamins and minerals, anti-cold, anti-allergic, derma products, antacids, anti-ulcerants, cardiac, analgesic, anti-bacterial, anti-fungal, and more. The company manufactures tablets, capsules, syrups, and external preparations under contract manufacturing and loan licensing agreements, for domestic and international markets. Its clients include notable pharmaceutical marketers such as Cadila Pharma and Viatris. Revenue is distributed between domestic pharmaceutical product sales and international exports, supporting scalable growth across geographies.
61GF Score
Get the complete analysis for NSE:SOTAC
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:SOTAC has been successfully added to your 
